Baird Medical Elevates Thyroid Microwave Ablation Training with Harvard Collaboration
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) has taken significant steps to advance training in Microwave Ablation (MWA) technology, specifically focusing on thyroid treatments. Recently, the company held an advanced training session coupled with an academic exchange in New Orleans, which emphasized its commitment to innovation in clinical practices and research collaboration.
This program was led by Dr. Emad Kandil, a renowned professor and the Ellis Hanna Chair in Surgery at Tulane University School of Medicine. Dr. Kandil is recognized as a key figure in thyroid ablation and endocrine surgery. Joining him was Dr. Gregory Randolph, the esteemed Professor of Otolaryngology–Head and Neck Surgery at Harvard Medical School. Dr. Randolph also holds the Claire and John Bertucci Endowed Chair in Thyroid Surgical Oncology. As a distinguished professor visiting Tulane on May 9, 2025, Dr. Randolph engaged in rich academic discussions with Dr. Kandil, focusing on various thyroid-related topics.
During the exchange, Dr. Randolph not only participated in meaningful dialogues but also took part in hands-on clinical observations and procedures alongside Dr. Kandil. The duo explored emerging technologies in thyroid surgery and deliberated on potential avenues for future research collaboration, enhancing the scope of their specialty. This initiative underscores Baird Medical's broader strategy to elevate the standards of thyroid care by collaborating with leaders in the medical field.
The company is dedicated to promoting the global adoption of innovative and minimally invasive therapeutic options. Baird Medical specializes in the research and development of advanced diagnostic and surgical instruments, harnessing technologies to improve patient outcomes through precision and efficiency.
Founded with a vision to enhance surgical care, Baird Medical has established strategic alliances with prominent academic institutions to pioneer the development of intelligent systems that assist healthcare providers in making informed diagnostic decisions. Its innovative devices have produced noticeable improvements in patient recovery and treatment experiences, reflecting the company's ethos of prioritizing patient-centric care.
In the United States alone, Baird Medical's FDA 510(k)-certified devices are currently utilized in over 30 respected hospitals and clinics, including notable institutions like Johns Hopkins Hospital, Tulane Medical Center, Weill Cornell Medicine, and Columbia University Medical Center. Additionally, Baird Medical holds a leading position in China regarding the distribution of thyroid microwave ablation devices and associated consumables, where its products are gradually making their mark in over 20 countries worldwide.
Moving forward, Baird Medical remains focused on nurturing collaborations that foster excellence in the field and push the limits of existing technologies. With ambitions that extend beyond merely providing surgical assistance, the company seeks to develop proactive solutions that will define the future of diagnostic and preventive healthcare. Through initiatives like the recent training program with Harvard, Baird Medical is not only advancing its mission but also ensuring that the standards of thyroid health care continue to evolve and improve as the field of medicine advances.